Topics

Videos

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, value & access advisor for Schoonveld Advisory and author of The Price of Global Health, comments on the future implications of the latest CMS drug price negotiations.

What Round II of Medicare Part D Drug Prices Signify for the Pharma Industry

Articles

A cross-sectional study investigates the impact of Dobbs v Jackson’s Women’s Health Organization on national support and personal interest.  

How Advance Provision, OTC Access to Abortion Medication Changed Pre- and Post-Dobbs Ruling

What factors influence their likelihood of receiving this form of obesity treatment?

The Association Between Semaglutide Initiation and Obese Individuals Without Diabetes

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today. 

Navigating Access and Reimbursement Through Uncertainty 

Podcasts

Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report. 

The Path Forward for Infused Biosimilars in the US

A panel examines the gross-to-net bubble across various product mixes, how pricing impacts market access, and more.  

Trade & Channel Strategies 2024: A GTN Bubble Balancing Act

Kevin O’Meara discusses how patient service teams influence adherence from Direct-to-Patient models. 

Trade & Channel Strategies 2024: The Role of Patient Service Teams in Driving Direct-to-Patient Adherence

Kevin O’Meara discusses Patient-Cetric 3.0 breakout session and the challenges of drug manufactures implementing Direct-to-Patient models.

Trade & Channel Strategies 2024: Key Challenges of Implementing Direct-to-Patient Models 

Breakout session explores how direct-to-patient models shorten the time to diagnosis and therapy to improve patient outcomes.

Trade & Channel Strategies 2024: Patient-Centric 3.0 — How Direct-to-Patient is the New Commercialization Model

Access Insights Conference delves into the latest obstacles,   while mapping out potential solutions to address them. 

Market Access